cas 1510311-17-7|| where to buy 5-bromo-2-methyl-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-3,4-dihydropyrimidin-4-one

Nom du produit:5-bromo-2-methyl-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-3,4-dihydropyrimidin-4-one

IUPAC Name:5-bromo-2-methyl-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-3,4-dihydropyrimidin-4-one

Unité d'emballage	Stock disponible	Prix($)
CM427892-250mg	5-6 Weeks	Ȑƿŵƿ
CM427892-500mg	5-6 Weeks	Ȑƿũȡ
CM427892-1g	5-6 Weeks	Ȑƿưũ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1510311-17-7 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1510311-17-7; Formule moléculaire:C9H9BrN4O2; Point de fusion:-; Code SMILES:CC1=NOC(CN2C(C)=NC=C(Br)C2=O)=N1; Densité:

: Numéro de catalogue:CM427892; Poids moléculaire:285.1; Point d'ébullition:; N° Mdl:MFCD22801743; Stockage:

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

: Oxadiazoles; Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.